Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors.
about
Recent advances in central cardiovascular control: sex, ROS, gas and inflammationProlactin and teleost ionocytes: new insights into cellular and molecular targets of prolactin in vertebrate epitheliaAngiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus.Soluble CD40 ligand and prolactin levels in migraine patients during interictal periodA prospective population-based cohort study of lactation and cardiovascular disease mortality: the HUNT study.Plasma prolactin level and risk of incident hypertension in postmenopausal women.Prolactin stimulates sodium and chloride ion channels in A6 renal epithelial cells.The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic ringsProlactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.Lactation and maternal subclinical cardiovascular disease among premenopausal womenAssociation between serum prolactin levels and insulin resistance in non-diabetic menMicrocirculation and atherothrombotic parameters in prolactinoma patients: a pilot study.Association Between Prolactin and Incidence of Cardiovascular Risk Factors in the Framingham Heart StudyLactation and maternal measures of subclinical cardiovascular disease.Hyperprolactinemia: pathophysiology and therapeutic approach.Hormonal changes in hemodialysis patients: Novel risk factors for mortality?Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma.Arterial Stiffness and Hypertension - Which Comes First?Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.Prolactin as a predictor of endothelial dysfunction and arterial stiffness progression in menopause.Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: a pilot study.High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients.The effect of prolactin levels on MPV in women with PCOS.A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations.The Association between Oligomenorrhea, Onset of Menopause and Metabolic Syndrome in Thai Postmenopausal Women
P2860
Q26752442-36C78ADA-6E4C-4378-AD3C-6632DD5156D1Q33896039-AD9EE5EC-D9F6-4F90-AF3A-2F4866BD6BD5Q34150500-EAEAA51A-CEEE-4E2F-BB2D-DDC32E0E11BAQ34981885-3C1EAE89-E0F7-413A-B9C5-79B6C57D9CCAQ35039393-F6ABAC74-29B3-423D-BACA-E7E5037E674AQ35114669-2CE30CAA-2145-4242-BC57-B746A7A95390Q35274029-C58B7BF8-B06C-42BB-BBC7-A99D18B5E82FQ35578519-3C75DC96-00EC-4CBF-8234-CB73D5BAD08FQ35758553-8ECDCF57-1D49-48C6-9775-9022A52E0054Q36059830-1F74B738-0AAA-496D-A358-8A50FF4C2DA8Q36338425-ADC81BD6-7C29-435C-A2CD-67379B4A6F4FQ36384958-11F31C91-B322-41EA-908A-0547F975CEB8Q36714142-FCAE8DA5-807B-4FB0-AD92-F2DA93FA46DBQ36802788-5325BEB0-343C-4AA2-B5BF-34E2F78389A6Q38570196-1FA362B2-AFA3-459E-9E35-DA45F080882FQ39369109-98DEB3F7-3C2E-4F5B-A929-AA7A0D8FAED2Q46014789-FC0ED9DB-2661-4921-947E-A11662634877Q47117381-3FDEC3D1-0B10-4948-ACB8-62347EAF8C65Q48370319-E169E5C9-803D-4BF7-AF3A-C0060433E7B6Q50780529-7A896AE5-FB48-49AD-ABB5-413445B7FB43Q50917186-79A5EC27-FFE1-4EB8-B1EE-60624BE4A01DQ51147441-763562DC-ADE9-43CC-ABDB-BA35050F7E10Q54221910-E63DF9B6-6161-43F0-BCCF-6FEF9DEDCAC2Q55669305-0EBB1E75-F068-408D-A152-A08B6F365188Q58781170-5CB35D03-8F7A-4E1F-B477-8813EE05858A
P2860
Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prolactin and preclinical athe ...... h cardiovascular risk factors.
@ast
Prolactin and preclinical athe ...... h cardiovascular risk factors.
@en
type
label
Prolactin and preclinical athe ...... h cardiovascular risk factors.
@ast
Prolactin and preclinical athe ...... h cardiovascular risk factors.
@en
prefLabel
Prolactin and preclinical athe ...... h cardiovascular risk factors.
@ast
Prolactin and preclinical athe ...... h cardiovascular risk factors.
@en
P2093
P1433
P1476
Prolactin and preclinical athe ...... h cardiovascular risk factors.
@en
P2093
Christos Papamichael
Dimitrios Rizos
George A Georgiopoulos
George Christodoulakos
Katerina Kyrkou
Kimon S Stamatelopoulos
Maria Alevizaki
Maria Creatsa
Maria Lykka
Petros P Sfikakis
P304
P356
10.1161/HYPERTENSIONAHA.109.132100
P407
P577
2009-05-18T00:00:00Z